Page last updated: 2024-10-23

astemizole and Cardiovascular Stroke

astemizole has been researched along with Cardiovascular Stroke in 2 studies

Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.

Research Excerpts

ExcerptRelevanceReference
"To clarify the mechanisms of enhanced cardiotoxic effects of astemizole in ischemic hearts, we examined the effects of astemizole on ventricular activation, effective refractory periods (ERPs), RT intervals, and incidence of programmed electrical stimulation (PES)-induced ventricular arrhythmias in the dog heart after myocardial infarction."7.70Effects of astemizole on ventricular activation, effective refractory periods, RT intervals, and programmed stimulation-induced ventricular arrhythmias in dog hearts with myocardial infarction. ( Hashimoto, H; Ikeda, Y; Nakamura, R; Nakashima, M; Nishimoto, M; Ohmura, T; Umemura, K; Watanabe, S, 1998)
"In order to clarify the arrhythmogenic effects of nonsedating antihistamines, we examined the effects of astemizole, a nonsedating antihistamine, on ventricular activation and RT intervals in a canine myocardial infarction model."7.69Effects of astemizole on ventricular activation delay and RT intervals in a canine myocardial infarction model. ( Hashimoto, H; Ikeda, Y; Nakashima, M; Nishimoto, M; Ohashi, K; Ohmura, T; Umemura, K; Watanabe, S, 1997)
"To clarify the mechanisms of enhanced cardiotoxic effects of astemizole in ischemic hearts, we examined the effects of astemizole on ventricular activation, effective refractory periods (ERPs), RT intervals, and incidence of programmed electrical stimulation (PES)-induced ventricular arrhythmias in the dog heart after myocardial infarction."3.70Effects of astemizole on ventricular activation, effective refractory periods, RT intervals, and programmed stimulation-induced ventricular arrhythmias in dog hearts with myocardial infarction. ( Hashimoto, H; Ikeda, Y; Nakamura, R; Nakashima, M; Nishimoto, M; Ohmura, T; Umemura, K; Watanabe, S, 1998)
"In order to clarify the arrhythmogenic effects of nonsedating antihistamines, we examined the effects of astemizole, a nonsedating antihistamine, on ventricular activation and RT intervals in a canine myocardial infarction model."3.69Effects of astemizole on ventricular activation delay and RT intervals in a canine myocardial infarction model. ( Hashimoto, H; Ikeda, Y; Nakashima, M; Nishimoto, M; Ohashi, K; Ohmura, T; Umemura, K; Watanabe, S, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishimoto, M2
Hashimoto, H2
Ohmura, T2
Ikeda, Y2
Watanabe, S2
Ohashi, K1
Umemura, K2
Nakashima, M2
Nakamura, R1

Other Studies

2 other studies available for astemizole and Cardiovascular Stroke

ArticleYear
Effects of astemizole on ventricular activation delay and RT intervals in a canine myocardial infarction model.
    Biological & pharmaceutical bulletin, 1997, Volume: 20, Issue:9

    Topics: Animals; Arrhythmias, Cardiac; Astemizole; Blood Pressure; Disease Models, Animal; Dogs; Dose-Respon

1997
Effects of astemizole on ventricular activation, effective refractory periods, RT intervals, and programmed stimulation-induced ventricular arrhythmias in dog hearts with myocardial infarction.
    Journal of cardiovascular pharmacology, 1998, Volume: 31, Issue:2

    Topics: Animals; Arrhythmias, Cardiac; Astemizole; Dogs; Dose-Response Relationship, Drug; Electrocardiograp

1998